HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >

Mucosal lesions in cutaneous lupus erythematosus successfully treated with hydroxychloroquine

This item is licensed under: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

Files in This Item:
Oral sci int_16_106.pdf1.92 MBPDFView/Open
Please use this identifier to cite or link to this item:

Title: Mucosal lesions in cutaneous lupus erythematosus successfully treated with hydroxychloroquine
Authors: Kamaguchi, Mayumi Browse this author
Iwata, Hiroaki Browse this author →KAKEN DB
Asaka, Takuya Browse this author →KAKEN DB
Shimizu, Hiroshi Browse this author →KAKEN DB
Kitagawa, Yoshimasa Browse this author →KAKEN DB
Keywords: cutaneous lupus erythematosus
mucosal lesion
Issue Date: Aug-2019
Publisher: John Wiley & Sons
Journal Title: Oral science international
Volume: 16
Issue: 2
Start Page: 106
End Page: 109
Publisher DOI: 10.1002/osi2.1006
Abstract: Cutaneous lupus erythematosus (CLE) is a rare, potentially disfiguring, chronic autoimmune disease with extremely variable skin and mucosal membrane manifestations. Hydroxychloroquine (HCQ) is an antimalarial drug that has been used in various countries to treat autoimmune diseases including CLE. HCQ was banned for a long time in Japan because of severe chloroquine retinopathy and was reapproved as a first-line treatment for CLE in 2015. There are no case reports describing the effectiveness of HCQ for CLE with oral mucosal lesions in the dental field. We present a case of CLE whose oral lesions were successfully treated with HCQ.
Rights: © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license
Type: article (author version)
Appears in Collections:北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 岩田 浩明

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 - Hokkaido University